there is a lot of talk of what's going on ? ... there is no...

there is a lot of talk of what's going on ? ... there is no update and what are they doing ? no update does not equal no action or laziness or incompetence. it's unrealistic to expect weekly updates.

as a few have said, I believe they are speaking to the regulators, working on dosing / patient numbers/ trial design. from there they know costs. from there they can work out how to fund it. once they know this they can push the Chinese etc etc etc. it's a pretty logical set of events that need to happen.

will it go well / how much Cash do we need / can they find non dilutive funding. dunno. but they are working on all this and I am sure they will update us when they can.

I have lost a fortune and I am not happy. but I also still believe in the science. I know it's all doom and gloom here, hence me rarely reading HC let alone adding my views, but imagine for a moment the following not doom and gloom scenario

1- fda likes the data and wants to help them get registered somehow
2- 2x2 confirm
3- reduced patients / timelines therefore reduced spend
4- tga approval
5 - we are not 100m short but a far smaller number
6- regional oa interest warms up as fda trial protocols approved
7 - potential to fill the gap with non dilutive / China upfront / options and hence no cap raise
8- board changes

I have no idea if any or all of the above are realistic but when I speak to Paul I am quite sure they aren't sitting around with their thumb up their backside. they know this is serious and they need to deliver. I am skeptical but I am waiting for fda feedback in a month or so and then from there reassess my thinking. until then, there is nothing to do but wait.

but cheer up folks. it ain't over yet.

my opinions